Adhera Therapeutics Competitors and Similar CompaniesClear all

Adhera Therapeutics's competitors and similar companies include Aquestive Therapeutics, STADA, Karyopharm Therapeutics and Apeloa Pharmaceutical.
Adhera Therapeutics
Adhera Therapeutics
Adhera Therapeutics (previously known as Marina Biotech) is a specialty pharmaceutical company.
Aquestive Therapeutics
Aquestive Therapeutics
Aquestive Therapeutics is a pharmaceutical company that is engaged in drug development using PharmFilm technology.
STADA
STADA
STADA Arzneimittel is a company engaged in the healthcare and pharmaceuticals business.
Karyopharm Therapeutics
Karyopharm Therapeutics
Karyopharm Therapeutics is a commercial-stage pharmaceutical company that pioneers in cancer therapies.
Apeloa Pharmaceutical
Apeloa Pharmaceutical
Apeloa Pharmaceutical (普洛药业股份有限公司) is a company that develops and produces pharmaceutical products.
Founding Date
Founding Date
1983
Founding Date
2004
Founding Date
1895
Founding Date
2008
Founding Date
1989
Type
Type
Public
Type
Public
Type
Public
Type
Public
Type
Public
Tags
Locations
Locations
Baton Rouge, US HQ
Locations
Warren, US HQ
Locations
Bad Vilbel, DE HQ
Beijing, CN
Hangzhou Shi, CN
Shanghai, CN
Bad Vilbel, DE
Budapest, HU
Vilnius, LT
see more
Locations
Newton, US HQ
Givatayim, IL
Locations
CN HQ
Employees
Employees
24243% increase
Employees
13017% decrease
Employees
12,33911% increase
Employees
22818% decrease
Employees
7,060
Valuation ($)
Valuation ($)
1.3 m
Valuation ($)
515.4 m
Valuation ($)
6 b
Valuation ($)
111.7 m
Valuation ($)
2.7 b

Financial

Revenue (est.)
Revenue (est.)
N/A
Revenue (est.)
$44.5m (FY, 2025)
Revenue (est.)
€3b (FY, 2020)
Revenue (est.)
$146.1m (FY, 2025)
Revenue (est.)
¥9.7b (FY, 2025)
Cost of goods
Cost of goods
N/A
Cost of goods
$18.6m (FY, 2025)
Cost of goods
€1.3b (FY, 2020)
Cost of goods
$5.9m (FY, 2025)
Cost of goods
¥7.2b (FY, 2025)
Gross profit
Gross profit
N/A
Gross profit
$26m (FY, 2025)
Gross profit
€1.7b (FY, 2020)
Gross profit
$140.1m (FY, 2025)
Gross profit
¥2.5b (FY, 2025)
Net income
Net income
($2.7m) (FY, 2022)
Net income
($83.8m) (FY, 2025)
Net income
€181.9m (FY, 2020)
Net income
($196m) (FY, 2025)
Net income
¥890.7m (FY, 2025)

Operating

Patents (US)
Patents (US)
N/A
Patents (US)
40 (Q1, 2018)
Patents (US)
2 (Nov, 2020)
Patents (US)
N/A
Patents (US)
N/A
Patents Issued
Patents Issued
N/A
Patents Issued
200 (Q1, 2018)
Patents Issued
N/A
Patents Issued
10 (FY, 2015)
Patents Issued
N/A

Funding

Total funding raised
Total funding raised
$ 6m
Total funding raised
N/A
Total funding raised
N/A
Total funding raised
$ 248.7m
Total funding raised
N/A
For sources of this data, please see the company profile

View Company Profiles

Aquestive Therapeutics
HQ
Warren, US
Employees
130↓ 17% decrease

Aquestive Therapeutics is a pharmaceutical company that is engaged in drug development using PharmFilm technology.

View company
STADA
HQ
Bad Vilbel, DE
Employees
12,339↑ 11% increase

STADA Arzneimittel is a company engaged in the healthcare and pharmaceuticals business.

View company
Karyopharm Therapeutics
HQ
Newton, US
Employees
228↓ 18% decrease

Karyopharm Therapeutics is a commercial-stage pharmaceutical company that pioneers in cancer therapies.

View company
Apeloa Pharmaceutical
HQ
CN
Employees
7,060

Apeloa Pharmaceutical (普洛药业股份有限公司) is a company that develops and produces pharmaceutical products.

View company